Gainers
Connexa Sports Technologies Inc. (NASDAQ: CNXA) shares jumped 124.2% to $0.1697 after falling 15% on Monday.
Avinger, Inc. (NASDAQ: AVGR) gained 63.9% to $9.95, adding to outsized gains from Monday. On Monday, Avinger shares soared 46.8% after the company announced the commercial launch of its Tigereye ST image-guided CTO crossing device.
Sezzle Inc. (NASDAQ: SEZL) shares climbed 46.6% to $18.95.
PHAXIAM Therapeutics S.A. (NASDAQ: PHXM) rose 30% to $5.17.
Elutia Inc. (NASDAQ: ELUT) shares gained 29.1% to $1.6006 after the company announced the sale of its Orthobiologics business unit to Berkeley Biologics LLC. Elutia announced $26 million private placement of 7,355,869 shares of common stock at $1.4275 per share.
Orchestra BioMed Holdings, Inc. (NASDAQ: OBIO) surged 24.4% to $10.50. The FDA granted an investigational device exemption to initiate BACKBEAT Study evaluating Orchestra biomed's atrioventricular interval modulation therapy (BACKBEAT CNT) for hypertensive patients who are indicated for a dual-chamber cardiac pacemaker.
Rackspace Technology, Inc. (NASDAQ: RXT) gained 20.2% to $1.78 after Raymond James upgraded the stock from Market Perform to Outperform and announced a $3.5 price target.
Eos Energy Enterprises, Inc. (NASDAQ: EOSE) jumped 16.6% to $2.65.
Neptune Wellness Solutions Inc. (NASDAQ: NEPT) rose 15% to $5.32 after falling 18% on Monday. Neptune Wellness announced intention to spinout Sprout Organics pursuant to the Morgan Stanley agreed to transaction.
Solowin Holdings (NASDAQ: SWIN) climbed 14.8% to $2.3882.
Navidea Biopharmaceuticals, Inc. (NYSE: NAVB) gained 13.5% to $0.1048.
Galera Therapeutics, Inc. (NASDAQ: GRTX) shares rose 13.2% to $0.2158. Galera scheduled a Type A meeting with the FDA to discuss next steps for its radiotherapy avasopasem.
Lichen China Limited (NASDAQ: LICN) gained 11.6% to $1.15.
TriSalus Life Sciences, ...
Benzinga
